LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹1.77 Cr | ₹8.95 Cr | ₹79 Cr | ₹8.81 Cr | ₹5.32 Cr |
What is the latest Cash Flow from Operating Activities ratio of LYKA LABS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹1.77 Cr |
Mar2023 | ₹8.95 Cr |
Mar2022 | ₹79 Cr |
Mar2021 | ₹8.81 Cr |
Mar2020 | ₹5.32 Cr |
How is Cash Flow from Operating Activities of LYKA LABS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹1.77 Cr | -80.20 | |
Mar2023 | ₹8.95 Cr | -88.70 | |
Mar2022 | ₹79 Cr | 799.30 | |
Mar2021 | ₹8.81 Cr | 65.55 | |
Mar2020 | ₹5.32 Cr | - |
Compare Cash Flow from Operating Activities of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹417.3 Cr | 2.2% | 5.6% | 9.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | 0.1% | -9.1% | 13.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,673.0 Cr | -1.6% | 6.5% | 47% | Stock Analytics | |
CIPLA | ₹118,908.0 Cr | 0.3% | -4.6% | -1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,106.0 Cr | -0.9% | -4.5% | 15.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,494.0 Cr | 0.4% | 6.5% | 4.1% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | 2.2% |
5.6% |
9.8% |
SENSEX | -0.4% |
0.3% |
8.7% |
You may also like the below Video Courses